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Phytoprostanes (PhytoPs) represent non-enzymatic metabolites of α-linolenic acid (ALA),
the essential omega-3 polyunsaturated fatty acid (PUFA) derived from plants. PhytoPs
are present in the plant kingdom and represent endogenous mediators capable of
protecting cells from oxidative stress damages in plants. Recently, it was found that such
metabolites are present in cooking oil in high quantities, and also that B1-PhytoPs protect
immature neurons from oxidant injury and promote differentiation of oligodendrocyte
progenitors through PPAR-γ activation. We report a novel and facile synthesis of natural
2,3-substituted cyclopentenone PhytoPs, 16-B1-PhytoP, and 9-L1-PhytoP. Our strategy
is based on reductive alkylation at the 2-position of 1,3-cyclopentanedione using a recent
protocol developed by Ramachary et al. and on a cross-coupling metathesis to access
conjugate dienone system. In conclusion, this strategy permitted access to B1- and
L1-PhytoPs in a relative short sequence process, and afford the possibility to easily
develop analogs of PhytoPs.
Keywords: phytoprostane, cross-metathesis, natural products, polyunsaturated fatty acids, oxygenated
metabolites
Introduction
Non-enzymatic production of biologically relevant compounds seems rather scarce in nature.
One of the reasons could be the lack of researchers willing to accept the idea that auto-oxidative
formation of metabolites could possess a primordial role in biology, and therefore to unravel their
hidden properties. While this idea is only starting to grow in the field of oxidative stress and
the production of non-enzymatically formed metabolites of polyunsaturated fatty acid (PUFA),
it is still rather uncommon. In 1990, Morrow and Roberts discovered isoprostanes (IsoPs),
compounds produced in human fluids and tissues by non-enzymatic free radical peroxidation
of arachidonic acid (C20:4 n-3, AA) in phospholipid membranes (Morrow et al., 1990). These
compounds later became the “gold standard” biomarker of lipid oxidative stress (Kadiiska et al.,
2005), but also showed many relevant biological activities (Jahn et al., 2008; Galano et al., 2015).
In 1998, Mueller and coworkers discovered that peroxidation of α-linolenic acid in plant (C18:3
n-3, ALA) lead to dinor-isoprostanes, later called Phytoprostanes (PhytoPs) (Parchmann and
Mueller, 1998; Jahn et al., 2010). They also represent a standard of oxidative stress in plants
(Durand et al., 2009), and are considered, like the jasmonate compounds, to be able to activate
genes implicated in the detoxification response, and many other response signals to protect
the plants (Durand et al., 2009). PhytoPs are also relevant to human, particularly to human
diet, being present in vegetable oil (Karg et al., 2007; Collado-González et al., 2015a,b), and
it was demonstrated that their level in humans can increase after high consumption of ALA
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(Barden et al., 2009). Recently, 2,3-substituted cyclopentenone
PhytoPs such as 16-B1-PhytoPs showed protective effects on
immature neurons from oxidant injury and on the differentiation
of oligodendrocyte progenitors through PPAR-γ activation
(Minghetti et al., 2014).
A few syntheses of such 2,3-substituted cyclopentenone
phytoprostanes are reported in the literature (El Fangour et al.,
2005; Schmidt and Boland, 2007; Perlikowska and Mikołajczyk,
2009, 2011; Vázquez-Romero et al., 2009, 2013; Beretta et al.,
2015), and our group developed the first ones in 2005, 9-
L1-PhytoP and 16-B1-PhytoP (El Fangour et al., 2005). Later,
Boland and coworkers developed a very elegant and rapid
synthesis of such compounds and analogs based on a 1,3-
cyclopentanedione functionalization and Heck or Sonogashira-
type coupling reactions (Schmidt and Boland, 2007).We believed
that a rapid and facile unexplored approach could also be carried
out based on a cross-metathesis strategy between conjugated
3-vinyl-cyclopentenone derivatives such as A and enone or
allyl unit partners to introduce the unsaturated side chain.
Derivatives such as A could be obtained from 2-alkylation of 1,3-
cyclopentanedione followed by introduction of the conjugated
dienone unit (Scheme 1). Interestingly, large variation at the 2-
position could be achieved using the elegant Ramachary protocol
for reductive alkylation of 1,3-cyclopentanedione (Ramachary
and Kishor, 2008). Here we described the rapid and facile
syntheses of 2,3-substituted cyclopentenone PhytoPs, 16-B1-
PhytoP and 9-L1-PhytoP based on the novel approach described
above.
Materials and Methods
All reactions requiring anhydrous conditions were conducted
in oven-dried glassware (120◦C for 12 h minimum), syringes,
and needles with magnetic stirring under nitrogen unless
mentioned otherwise. Anhydrous THF and Et2O were obtained
from the Innovative Technology PureSolv™ PS-400 solvent
purification system. Other solvents and reagents were used as
obtained from the supplier (Acros or Aldrich) unless otherwise
noted. Lipase acrylic resin from Candida antarctica ≥5000U/g,
recombinant, expressed in Aspergillus niger was purchased from
SCHEME 1 | Retrosynthetic analyses of 1 and 2 from 1,3-cyclopentanedione.
Sigma-Aldrich. Reactions were monitored by TLC using plates
precoated with silica gel 60 (Merck). Reaction components were
visualized by using a 254 nm UV lamp, treatment with acidic
p-anisaldehyde stain followed by gentle heating. Organic layers
were dried with anhydrous MgSO4 unless otherwise stated.
Column chromatography was performed by using silica gel 40–
63µm. Optical rotations were measured with a Jasco P2000
digital polarimeter at 20◦C. Concentrations c reported for the
optical rotation data are given in g/100mL. Infrared data are
reported as wavenumbers (cm−1). ES-MS data were obtained by
positive electrospray ionization methods. 1H NMR spectra were
obtained at 300 or 500MHz on Bruker spectrometers (AMX300
or Avance 500MHz). The spectra were recorded in CDCl3
(internal reference at δ = 7.26 ppm) unless otherwise noted. The
1H NMR spectra are reported as follows: chemical shift in ppm
[multiplicity, coupling constant(s) J in Hz, relative integral]. The
multiplicities are defined as follows: br., broad; m, multiplet;
AB, AB system; s, singlet; d, doublet; t, triplet; or combinations
thereof. Selected 13C NMR spectra were recorded by using a J-
modulated sequence, and the central peak of the CDCl3 triplet
was used as the internal reference (δ = 77.16 ppm) and MeOD
(fixed at δ = 49.0 ppm). The NMR spectra were assigned by
homonuclear (1H–1H) and heteronuclear (1H–13C) correlation
spectroscopy (COSY45, HSQC, HMBC). Infrared spectra were
obtained using Perkin-Elmer Spectrum One Spectrometer.
They were reported as wavenumber (cm−1) of significant
peaks.
2-Ethyl-3-methoxycyclopent-2-enone (3)
To a solution of 2-ethylcyclopentane-1,3-dione (1 g, 7.9mmol,
1.0 eq) in 30mL Et2O and 3mL of MeOH, at 0
◦C, TMS-
diazomethane solution was added (2M in Et2O, 6.9mL,
9.9mmol, 1.75 eq) over 1min. After 10min at 0◦C and 2 h at
room temperature, the reaction mixture was concentrated under
reduced pressure. The crude was directly used in the next step
without further purification. Rf = 0.45 (95/5: EtOAc/MeOH);
1H
NMR (300MHz, CDCl3): 3.89 (s, 3H), 2.61–2.58 (m, 2H), 2.40–
2.36 (m, 2H), 2.10 (q, J= 7.5Hz, 2H), 0.94 (t, J= 7.5Hz, 3H); 13C
NMR (75MHz, CDCl3): δ = 204.7, 184.2, 122.1, 56.2, 33.4, 24.4,
14.4, 12.5.
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2-Ethyl-3-vinylcyclopent-2-enone (4)
To a crude solution of 2-ethyl-3-methoxycyclopent-2-enone 3
(theory∼ 7.9mmol, 1.0 eq) in anhydrous THF (40mL) at−78◦C,
a vinyl magnesium bromide solution (1M in THF, 11.9mL,
11.9mmol, 1.5 eq) was added dropwise. After 30min at −78◦C
and 1 h at room temperature, the crude mixture was added to
a solution of HCl (1M, 50mL) and ice (80 g). The mixture was
vigorously stirred 2 h and extracted with EtOAc (4×50 mL). The
combined organic layers were washed with brine (3 × 50mL),
dried over anhydrous MgSO4, filtered and the solvents were
removed under reduced pressure. The crude of the reaction
was purified under silica gel chromatography (95/5 to 80/20:
pentane/EtOAc). 663mg of compound 4 was obtained (61%
yield, 2 steps). Rf = 0.63 (50/50: cyclohexane/EtOAc);
1H NMR
(300MHz, CDCl3): δ = 6.89 (dd, J = 10.7, 17.4Hz, 1H), 5.70
(dd, J = 1.0, 17.4Hz, 1H), 5.46 (dd, J = 1.0, 10.7Hz, 1H); 2.62–
2.59 (m, 2H); 2.39–2.36 (m, 2H), 2.25 (q, J = 7.6Hz, 2H), 0.97
(J = 7.6Hz, 3H); 13C NMR (75 MHz, CDCl3): δ = 209.5, 162.9,
143.0, 131.0, 120.7, 33.7, 24.9, 16.2, 13.3; HRMS (ESI+) calculated
for C9H13O [M+H]
+ 137.0966, found 137.0957.
Methyl 9-hydroxyundec-10-enoate (5)
To a solution of methyl 10-undecenoate (1 g, 5mmol, 1 eq) in
16mL of CH2Cl2, SeO2 (1.11 g, 10mmol, 2 eq) and tert-butyl
hydroperoxide (5.5M in decane, 6.5mL, 35mmol, 7 eq) were
added. The mixture was heated under reflux overnight. After
cooling, a solution of FeSO4 (11 g) and citric acid (3.5 g) in water
(40mL) was added slowly. The reaction mixture was extracted
with Et2O (3×50mL). The combined organic layers were washed
with brine (3 × 50mL), dried over anhydrous MgSO4, filtered
and the solvents were removed without vacuum. The crude of
the reaction was purified under silica gel chromatography (90/0
to 60/40: pentane/Et2O) to give 659mg of 5 (61% yield). Rf = 0.4
(70/30: cyclohexane/EtOAc); 1H NMR (300 MHz, CDCl3): δ =
5.83 (ddd, J = 6.3, 10.4, 17.2Hz, 1H), 5.18 (dt, J = 1.3, 17.2Hz,
1H), 5.06 (dt, J = 1.2, 10.4Hz, 1H), 4.05 (q, J = 6.3Hz, 1H), 3.63
(s, 3H), 2.26 (t, J = 7.5Hz, 2 H), 1.65–1.46 (m, 5H), 1.32–1.21
(m, 8H); 13C NMR (75MHz, CDCl3): δ = 174.2, 141.3, 114.4,
73.1, 51.3, 36.9, 34.0, 29.2, 29.0, 28.9, 25.1, 24.8; HRMS (ESI+)
calculated for C12H23O3 [M+H]
+ 215.1647, found 215.1658.
Methyl 9-oxoundec-10-enoate (6)
To a solution of oxalyl chloride (304µL, 3.5mmol, 1.5 eq) in
15mL of CH2Cl2 at −78
◦C, DMSO (497µL, 7mmol, 3 eq) was
added dropwise. The mixture was stirred 10min and a solution
of 5 (500mg, 2.33mmol, 1 eq) in 5mL of CH2Cl2was added. The
crude was stirred 20min and Et3N (1.95mL, 14mmol, 6 eq) was
added. After stirring 2 h at room temperature, water (50mL) was
added. The layers were separated. The aqueous one was extracted
with CH2Cl2 (2 × 25mL) and the combined organic layers
were washed with water (25mL), saturated aqueous solution
of NaHCO3 (25ml), brine (20mL) and dried over anhydrous
MgSO4. The solvents were removed without vacuum. The crude
of the reaction was purified under silica gel chromatography
(95/5 to 80/20: pentane/Et2O) to give 389mg of 6 (79% yield). Rf
= 0.6 (50/50: cyclohexane/EtOAc); 1HNMR (300 MHz, CDCl3):
δ = 6.32 (dd, J = 10.3, 17.6Hz, 1H), 6.17 (dd, J 1.2, 17.6Hz,
1H), 5.77 (dd, J = 1.2, 10.3Hz, 1H), 3.63 (s, 3H), 2.54 (t, J =
7.4Hz, 2H), 2.26 (t, J= 7.5Hz, 2H), 1.64–1.56 (m, 4H), 1.36–1.24
(m, 6H); 13C NMR (75MHz, CDCl3): δ = 200.9, 174.1, 136.5,
127.3, 51.3, 39.5, 33.9, 28.9 (2 C), 28.8, 24.8, 28.8; HRMS (ESI+)
calculated for C12H21O3 [M+H]
+ 213.1491, found 213.1471.
Enzymatic Resolution of Methyl
9-hydroxyundec-10-enoate (5)
To a solution of methyl 9-hydroxyundec-10-enoate 5 (1.2 g,
5.6mmol, 1 eq) in hexane (5.2mL) Candida antarctica lipase B
(240mg, 20% w/w) and vinyl acetate (5.2mL, 56mmol, 10 eq)
were added. The reaction mixture was stirred overnight and
filtered. The solvents were removed under reduced pressure.
The crude of the reaction was purified under silica gel
chromatography (90/10 to 60/40: pentane/Et2O) to give 657mg
of acetylated product (R)-5-Ac (93%ee, 46% yield) and 545mg of
free hydroxylated (S)-5 (45% yield, 99% ee, [α]20D = −5.3 (c 10,
CHCl3).
(R)-5-Ac was deacetylated in the presence of K2CO3 (1.06 g,
7.7mmol, 3 eq) in MeOH (50mL).The mixture was stirred 5 h
and brine (150ml) was added. The crude was extracted with
pentane/Et2O 1/1 (3× 150mL). The organic layers were washed
with brine (3 × 100mL), dried over anhydrous MgSO4 and
evaporated slowly under controlled vacuum to obtain 505mg of
(R)-5 (92% yield). (R)-5 was enzymatically resolved one more
time with CALB, deacetylated with K2CO3 and analyzed to give
333mg of (R)-5 (83% yield, ee= 99%).
Esterification of (R)-5 and (S)-5 with 2,4-dinitrobenzyl
chloride in pyridine gave the corresponding esters, which
were analyzed by chiral HPLC (Chiralcel OD R©, 95/5:
Hexane/isopropanol, 0.7ml/min, λ = 254 nm) to give ee =
99% for (S)-5-ester (tr= 18.1min) and ee = 93% for (R)-5-ester
(tr= 23.6min).
Determination of Stereochemistry of 5
One aliquot of (S)-5 was esterified with (S)-acetyl phenyl acetic
acid and (R)-acetyl phenyl acetic acid in presence of EDCI,
DMAP in CH2Cl2. In the same way, (R)-5 was esterified. With
the four diastereoisomers in hand, the stereochemistry of (S)-5
and (R)-5 was determined as previously described (Chataigner
et al., 1998).
9-Oxo-9-L1-PhytoP (9)
To a mixture of 4 (200mg, 1.47mmol, 1 eq) and 6 (935mg,
4.4mmol, 3 eq) in carefully degassed CH2Cl2 (30mL) Hoveyda
Grubbs 2nd generation catalyst (69mg, 0.11mmol, 0.025 eq) was
added. The mixture was heated 5 h under reflux. The crude was
evaporated without heating with celite R© and rapidly purified
under silica gel chromatography (100/0 to 80/20: CH2Cl2/Et2O).
The 9-oxo-9-L1-PhytoP methyl ester 8 was slightly degraded by
silica gel and contaminated by dimer of 4 and 6. The mixture was
used directly in the next step.
To a solution of previously recovered 9-oxo-9-L1-PhytoP
methyl ester 8 (and dimers) in MeCN (20mL) and phosphate
buffer (20mL, pH = 7) CALB (20mg, 2% w/w) was added.
The reaction mixture was stirred overnight. The crude was
extracted with CH2Cl2 (3 × 50mL). The organic layers were
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washed with brine (2 × 50mL) and dried over anhydrous
MgSO4.The solvents were removed under vacuum. The crude of
the reaction was purified under silica gel chromatography (100/0
to 98/2: CH2Cl2/MeOH) to give 260mg of 9-oxo-9-L1-PhytoP
9 (58% yield, 2 steps) with 5% of cis isomer. Rf = 0.25 (95/5:
CH2Cl2/MeOH);
1H NMR (300MHz, CDCl3): δ = 7.59 (d, J =
15.9Hz, 1H), 6.51 (d, J = 15.9Hz, 1H), 2.65–2.58 (m, 4H), 2.45–
2.42 (m, 2H), 2.38–2.27 (m, 4H), 1.63–1.56 (m, 4 H), 1.36–1.23
(m, 6H), 1.00 (t, J = 7.5Hz, 3H); 13C NMR (75MHz, CDCl3):
δ = 209.0, 200.1, 179.3, 159.7, 149.1, 133.9, 130.5, 41.4, 33.9,
33.8, 28.9, 28.8, 28.7, 25.3, 24.5, 23.8, 16.7, 13.5; HRMS (ESI+)
calculated for C18H27O4 [M+H]
+ 307.1909, found 307.1897.
9-L1-PhytoP Methyl Ester ((S)-7)
To a mixture of 4 (109mg, 0.8mmol, 1 eq) and (S)-5 (214mg,
1mmol, 1.25 eq) in carefully degassed CH2Cl2 (15mL) Hoveyda
Grubbs 2nd generation catalyst (12.5mg, 0.02mmol, 0.025 eq)
was added. The mixture was stirred for 2 days. A new crop
of catalyst (12.5mg) was added and the reaction was stirred
for 3 more days. To the reaction mixture celite R© was added
followed by evaporation of the solvents without heating, then
rapid purification under silica gel chromatography (95/5 to 50/50:
CH2Cl2/EtOAc). 103mg of 9-L1-PhytoP methyl ester (S)-7 was
obtained (40% yield). Rf = 0.24 (80/20: CH2Cl2/EtOAc);
1H
NMR (300MHz, CDCl3): δ = 6.74 (d, J = 15.7Hz, 1H), 6.19
(dd, J = 5.9, 15.7Hz, 1H), 4.27–4.23 (m, 1H), 3.58 (s, 3H), 2.58–
2.55 (m, 2H), 2.46 (sl, 1H), 2.35–2.31 (m, 2H), 2.25–2.18 (m,
4H), 1.57–1.51 (m, 4H), 1.36–1.20 (m, 8H), 0.93 (t, J = 7.5Hz,
3H); 13C NMR (75MHz, CDCl3): δ = 209.5, 174.2, 162.9, 142.4,
140.5, 123.4, 72.1, 51.3, 37.1, 33.9, 33.7, 29.2, 29.0, 28.9, 25.5, 25.2,
24.7, 16.2, 13.3; HRMS (ESI+) calculated for C19H31O4 [M+H]
+
323.2222, found 323.2207.
Ent-9-L1-PhytoP Methyl Ester ((R)-7)
Similar to the above, ent-9-L1-PhytoP methyl ester (R)-7 was
obtained from 4 and (R)-5 in similar yield (108mg, 42% yield).
Rf = 0.24 (80/20: CH2Cl2/EtOAc);
1H NMR (300MHz, CDCl3):
δ = 6.76 (d, J= 15.7Hz, 1H), 6.20 (dd, J= 5.9, 15.7Hz, 1H), 4.29–
4.25 (m, 1H), 3.61 (s, 3H), 2.60–2.57 (m, 2H), 2.38–2.35 (m, 2H),
2.28–2.21 (m, 4H), 2.12 (sl, 1H), 1.59–1.53 (m, 4H), 1.36–1.23
(m, 8H), 0.97 (t, J = 7.5Hz, 3H); 13C NMR (75 MHz, CDCl3):
δ = 209.4, 174.2, 162.7, 142.6, 140.2, 123.6, 72.2, 51.3, 37.1, 33.9,
33.8, 29.2, 29.0, 28.9, 25.5, 25.2, 24.7, 16.2, 13.3.
9-L1-PhytoP (1)
To a solution of 9-L1-PhytoP methyl ester (S)-7 (80mg,
0.248mmol, 1 eq) in MeCN (4.5mL) and phosphate buffer
(4.5mL, pH = 7) CALB (1.6mg, 2% w/w) was added. The
reaction mixture was stirred for 1 day. The crude was extracted
with EtOAc (3 × 10mL). The organic layers were washed with
brine (2 × 10mL) and dried over anhydrous MgSO4. The
solvents were removed under vacuum. The crude of the reaction
was purified under silica gel chromatography (50/50 to 25/75:
CH2Cl2/EtOAc) to give 63.4mg of 9-L1-PhytoP 1 (83% yield).
Rf = 0.20 (95/5: CH2Cl2/MeOH);
1H NMR (500MHz, CDCl3):
δ = 6.81 (d, J = 15.7Hz, 1H), 6.25 (dd, J = 6.0, 15.7Hz,
1H), 4.34 (q, J = 6Hz, 1H), 2.66–2.2.64 (m, 2H), 2.45–2.43 (m,
2H), 2.35 (t, J = 7.5Hz, 2H), 2.31 (q, J = 7.5Hz, 2H), 1.65–
1.60 (m, 4H), 1.36–1.33 (m, 8H), 1.01 (t, J = 7.5Hz, 3H); 13C
NMR (125MHz, CDCl3): δ = 211.1, 180.3, 164.2, 144.2, 141.4,
125.2, 73.8, 38.5, 35.2(2C), 30.6, 30.5, 30.3, 27.0, 26.6, 26.0, 17.7,
14.9; HRMS (ESI+) calculated for C18H29O4 [M+H]
+ 309.2066,
found 309.2070; [α]20D = −19.3 (c 10, CHCl3).
Ent-9-L1-PhytoP (ent-1)
Similar to the above, the ent-9-L1-PhytoP (ent-1) was
obtained from (R)-7 (69.2mg, 85% yield). Rf = 0.20 (95/5:
CH2Cl2/MeOH);
1H NMR (500MHz, CDCl3): δ = 6.81 (d, J =
15.7Hz, 1H), 6.25 (dd, J = 6.0, 15.7Hz, 1H), 4.34 (q, J = 6Hz,
1H), 2.65–2.2.64 (m, 2H), 2.45–2.42 (m, 2H), 2.35 (t, J = 7.5Hz,
2H), 2.31 (q, J = 7.5Hz, 2H), 1.65–1.60 (m, 4H), 1.36–1.33 (m,
8H), 1.01 (t, J = 7.5Hz, 3H); 13C NMR (125MHz, CDCl3): δ =
211.1, 180.5, 164.3, 144.1, 141.5, 125.2, 73.8, 38.5, 35.3, 35.2, 30.6,
30.5, 30.3, 27.0, 26.6, 26.0, 17.7, 14.9; HRMS (ESI+) calculated for
C18H29O4 [M+H]
+ 309.2066, found 309.2043; [α]20D = +19.1 (c
10, CHCl3).
Methyl 8-oxooctanoate (10)
In a solution of cyclooctene (1.95mL, 15mmol, 1 eq) and
Na2CO3 (400mg, 3.75mmol, 0.25 eq) in CH2Cl2/MeOH
(45mL/5mL), at −78◦C, a flow of generated ozone/air was
bubbled 3 h, until a blue color appeared. After elimination of
ozone excess by bubbling nitrogen, the reaction mixture was
warmed to room temperature, then the solution was filtered to
remove excess Na2CO3. The solvents were evaporated under
reduced pressure. CH2Cl2(40mL) was added to the crude
reaction mixture, then Et3N (3.13mL, 22.5mmol, 1.5 eq) and
Ac2O (3.9mL, 41.5mmol, 2.75 eq) were added successively
dropwise. The mixture was stirred overnight at rt, washed
with 0.1N HCl solution (2 × 30mL), 1N NaOH solution
(2 × 30mL), water (30mL), and brine (2 × 30 mL). The organic
layer was dried over anhydrous MgSO4 and evaporated under
reduced pressure. The crude was purified under silica gel
chromatography (95/5 to 90/10: cyclohexane/EtOAc) to give
1.78 g of 10 (69% yield). Rf = 0.33 (80/20: cyclohexane/EtOAc);
1H NMR (300MHz, CDCl3): δ = 9.68 (t, J = 1.8Hz, 1H), 3.58
(s, 3H), 2.35 (dt, J = 1.8, 7.3Hz, 2H), 2.23 (t, J = 7.5Hz, 2H),
1.58–1.51 (m, 4H), 1.29–1.24 (m, 4H); 13C NMR (75MHz,
CDCl3): δ = 202.5, 174.0, 51.3, 43.6, 33.8, 28.8, 28.6, 24.5, 21.7;
HRMS (ESI+) calculated for C9H17O3 [M+H]
+ 173.1178, found
173.1184.
Methyl 8-(2-methoxy-5-oxocyclopent-1-
enyl)Octanoate (11)
To a solution of 1,3-cyclopentanedione (456mg, 4.65mmol, 1 eq)
in CH2Cl2 (15mL) at room temperature methyl 8-oxooctanoate
10 (1.2 g, 6.96mmol, 1.5 eq), Hantzsch ester (1.3 g, 5.1mmol,
1.1 eq), and L-proline (27mg, 0.23mmol, 0.05 eq) were added
successively. The reaction mixture was stirred 4 h and the solvent
was removed by evaporation under reduced pressure. A mixture
of solvents Et2O/MeOH 9/1 (15mL) was added to the crude and
a solution of (trimethylsilyl)diazomethane (2M in Et2O, 4.64mL,
9.28mmol, 2 eq) was added dropwise. The mixture was stirred
30min and solvents were evaporated under reduced pressure.
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The crude was purified under silica gel chromatography (75/25
to 50/50: CH2Cl2/EtOAc) to give 1.15 g of 11 (91% yield). Rf =
0.44 (95/5: EtOAc/MeOH); 1H NMR (300 MHz, CDCl3): 3.87
(s, 3H), 3.59 (s, 3H), 2.61–2.58 (m, 2H), 2.38–2.35 (m, 2H), 2.22
(t, J = 7.4Hz, 2H), 2.04 (t, J = 7.2Hz, 2 H), 1.57–1.50 (m, 2H),
1.35–1.19 (m, 8H);13C NMR (75MHz, CDCl3): δ = 204.8, 184.5,
174.2, 120.8, 56.2, 51.3, 34.0, 33.4, 29.2, 28.9, 28.8, 27.7, 24.8, 24.3,
21.1; HRMS (ESI+) calculated for C15H25O4 [M+H]
+ 269.1753,
found 269.1745.
8-(2-methoxy-5-oxocyclopent-1-enyl)Octanoic
Acid (12)
To a solution of methyl ester 11 (1.4 g, 5.22mmol, 1 eq) in MeCN
(50mL) and phosphate buffer (50mL, pH = 7) CALB (28mg,
2% w/w) was added. The reaction mixture was stirred for 2
days. After adding NaCl powder, the crude was extracted with
EtOAc (3 × 50mL). The organic layers were washed with brine
(2×25mL), and dried over anhydrousMgSO4. The solvents were
removed under vacuum. The crude of the reaction mixture (12)
(1.342 g) was used directly in the next step.1H NMR (300MHz,
CDCl3): 3.90 (s, 3H), 2.63–2.60 (m, 2H), 2.43–2.40 (m, 2H), 2.29
(t, J = 7.5Hz, 2H), 2.09–2.00 (m, 2 H), 1.60–1.56 (m, 2H), 1.36–
1.20 (m, 8H);13CNMR (75MHz, CDCl3): δ = 205.3, 184.9, 179.0,
120.9, 56.3, 33.9, 33.3, 29.2, 28.9, 28.8, 27.7, 24.6, 24.4, 21.0.
Methyl 8-(5-oxo-2-vinylcyclopent-1-
enyl)Octanoate (13)
To a solution of 12 (theory: 5.22mmol, 1 eq), in anhydrous THF
(55mL), at −78◦C, a vinyl magnesium bromide solution (1M
in THF, 26.4mL, 26.4mmol, 5 eq) was added. After 30min at
−78◦C and 2 h at room temperature, the crude reaction mixture
was added to a solution of HCl (1 M, 150mL) and ice (150 g).
The mixture was vigorously stirred 2 h and extracted with EtOAc
(4 × 100mL). The combined organic layers were washed with
brine (3 × 50mL), dried over anhydrous MgSO4, filtered and
the solvents were removed under reduced pressure. A mixture of
solvents Et2O/MeOH 9/1 (15mL) was added to the crude extract
and a solution of (trimethylsilyl)diazomethane (2M in heptane,
3.3mL, 6.6mmol, 1.25 eq) was added dropwise. The mixture
was stirred 30min and solvents were evaporated under reduced
pressure. The crude of the reaction was purified under silica
gel chromatography (95/5 to 80/20: pentane/EtOAc). 686µg of
compound 13was obtained (50% yield, 3 steps). Rf = 0.57 (50/50:
cyclohexane/EtOAc); 1HNMR (300 MHz, CDCl3): δ = 6.88 (dd,
J = 10.7, 17.4Hz, 1H), 5.71 (dd, J = 0.9, 17.4Hz, 1H), 5.47 (d,
J = 10.7Hz, 1H), 3.62 (s, 3H), 2.64–2.61 (m, 2H), 2.40–2.37 (m,
2H), 2.24 (q, J = 7.5Hz, 4H), 1.59–1.54 (m, 2H), 1.38–1.26 (m,
8H); 13C NMR (75MHz, CDCl3): δ = 209.6, 174.2, 163.4, 141.7,
131.2, 120.7, 51.3, 34.0, 33.6, 29.3, 28.9 (2C), 28.7, 24.9, 24.8,
22.9; HRMS (ESI+) calculated for C16H25O3 [M+H]
+ 265.1804,
found 265.1819.
(3S,6S,E)-Oct-4-ene-3,6-diol (+)-14
At −5◦C, a solution of BuLi (1.6M in hexanes, 5.64mL, 9mmol,
1.3 eq) was added dropwise to a solution of freshly distillated
2,2,6,6-tetramethylpyperidine (1.52mL, 9mmol, 1.3 eq) in
anhydrous tBuOMe (3.5mL). The reaction was stirred 5min
at −5◦C and 20min at room temperature. After cooling at
−5◦C, (S)-1,2-epoxybutane (500µL, 6.93mmol, 1 eq) was added
dropwise. The reaction was stirred 6 h at −5◦C and overnight
at room temperature. MeOH (10mL) was added and then
the reaction mixture was stirred 10min and evaporated with
celite R© under vacuum. The crude was purified under silica gel
chromatography (75/25 to 50/50: pentane/EtOAc) to give 149mg
of (+)-14 (36% yield). Rf = 0.1 (70/30: cyclohexane/EtOAc);
1H
NMR (300MHz, CDCl3): 5.61–5.59 (m, 2H), 4.00–3.94 (m, 2H),
2.35 (sl, 2H), 1.59–1.44 (m, 4H), 0.87 (t, J = 7.4Hz, 3H); 13C
NMR (75MHz, CDCl3): δ = 133.8, 73.7, 30.0, 9.6; [α]
20
D = +21.7
(c 10, CHCl3).
(3R,6R,E)-Oct-4-ene-3,6-diol (−)-14
Similar to the above, (R)-1,2-epoxybutane (500µL, 6.93mmol)
gave access to compound (−)-14 (160mg, 38% yield). Rf = 0.1
(70/30: cyclohexane/EtOAc); 1HNMR (300 MHz, CDCl3): 5.65–
5.63 (m, 2H), 4.03–3.97 (m, 2H), 1.83 (sl, 2H), 1.60–1.47 (m, 4H),
0.89 (t, J = 7.4Hz, 3H); 13C NMR (75MHz, CDCl3): δ =133.7,
73.7, 30.0, 9.6; [α]20D = −20.0 (c 10, CHCl3).
16-Oxo-16-B1-PhytoP (16)
To a mixture of 13 (200mg, 0.75mmol, 1 eq) and pent-1-en-
3-one (150µL, 1.5mmol, 2eq) in carefully degassed CH2Cl2
(15mL) Hoveyda Grubbs 2nd generation catalyst (11.8mg,
0.019mmol, 0.025 eq) was added. The mixture was heated
4 h under reflux. To the reaction mixture celite R© was added,
followed by evaporation of the solvents without heating, and
rapidly purified under silica gel chromatography (100/0 to 80/20:
CH2Cl2/Et2O). The 16-oxo-16-B1-PhytoP methyl ester 16 was
slightly degraded by silica gel and contaminated by byproducts.
The mixture was used directly in the next step. To a solution
of contaminated 16-oxo-16-B1-PhytoP methyl ester 16 in MeCN
(8.5mL) and phosphate buffer (8.5mL, pH = 7) CALB (36mg,
20% w/w) was added. The reaction mixture was stirred 5 h. After
filtration, the crude mixture was extracted with EtOAc (3 ×
50mL). The organic layers were washed with brine (2 × 25mL)
and dried over anhydrous MgSO4. The solvents were removed
under vacuum. The crude of the reaction was purified under
silica gel chromatography (100/0 to 90/10: CH2Cl2/MeOH) to
give 80.6mg of 16-oxo-16-B1-PhytoP 17 (47% yield, 2 steps). Rf
= 0.39 (95/5: CH2Cl2/MeOH);
1HNMR (300MHz, CDCl3): δ =
7.60 (d, J= 15.9Hz, 1H), 6.53 (d, J= 15.9Hz, 1H), 2.70–2.62 (m,
4H), 2.46–2.43 (m, 2H), 2.34–2.27 (m, 4H), 1.60–1.56 (m, 2 H),
1.40–1.23 (m, 8H), 1.13 (t, J = 7.2Hz, 3H); 13C NMR (75 MHz,
CDCl3): δ = 209.0, 200.5, 179.31, 160.1, 147.8, 134.0, 130.2, 34.7,
33.8, 33.7, 29.2, 28.8 (2C), 28.7, 25.3, 24.5, 23.3, 7.8; HRMS (ESI+)
calculated for C18H27O4 [M+H]
+ 307.1909, found 307.1895.
16-B1-PhytoP Methyl Ester (S)-15
To a mixture of 13 (90mg, 0.34mmol, 1 eq) and (-)-14 (35mg,
0.24mmol, 0.7 eq) in carefully degassed CH2Cl2 (7mL) Hoveyda
Grubbs 2nd generation catalyst (5.3mg, 0.0085mmol, 0.025 eq)
was added. The mixture was stirred for 4 days. New crops
of catalyst (5.3mg) were added each day. To the reaction
mixture celite R© was added, followed by evaporation of the
solvents without heating, and rapid purification under silica gel
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chromatography (95/5 to 80/20: CH2Cl2/EtOAc). 53.6mg of 16-
B1-PhytoP methyl ester (S)-15 was obtained (49% yield). Rf =
0.26 (80/20: CH2Cl2/EtOAc);
1H NMR (300 MHz, CDCl3): δ =
6.74 (d, J = 15.7Hz, 1H), 6.20 (dd, J = 5.8, 15.7Hz, 1H), 4.23–
4.18 (m, 1H), 3.59 (s, 3H), 2.60–2.57 (m, 2H), 2.39–2.33 (m, 3H),
2.21 (q, J = 7.5Hz, 4H), 1.62–1.51 (m, 4H), 1.34–1.19 (m, 8H),
0.92 (t, J = 7.3Hz, 3H); 13C NMR (75MHz, CDCl3): δ = 209.5,
174.3, 163.2, 141.1, 140.1, 123.8, 73.4, 51.3, 33.9, 33.7, 30.0, 29.1,
28.9, 28.8, 28.6, 25.5, 24.7, 22.8, 9.5.
Ent-16-B1-PhytoP Methyl Ester (R)-15
Similar to the above, from (+)-14 the reaction gave ent-16-
B1-PhytoP methyl ester (R)-15 (52.6mg, 53% yield). Rf = 0.26
(80/20: CH2Cl2/EtOAc);
1H NMR (300MHz, CDCl3): δ = 6.76
(d, J= 15.7Hz, 1H), 6.21 (dd, J= 5.8, 15.7Hz, 1H), 4.25–4.20 (m,
1H), 3.62 (s, 3H), 2.62–2.59 (m, 2H), 2.39–2.36 (m, 2H), 2.21 (q,
J = 7.6Hz, 4H), 2.13 (s, 1H), 1.64–1.53 (m, 4H), 1.37–1.23 (m,
8H), 0.95 (t, J = 7.3Hz, 3H); 13C NMR (75MHz, CDCl3): δ =
209.5, 174.3, 163.1, 141.2, 139.9, 123.9, 73.5, 51.3, 33.9, 33.7, 30.1,
29.1, 28.9, 28.8, 28.6, 25.5, 24.7, 22.8, 9.5.
16-B1-PhytoP (2)
To a solution of 16-B1-PhytoP methyl ester (S)-15 (50mg,
0.155mmol, 1 eq) in MeCN (2.6mL) and phosphate buffer
(2.6mL, pH= 7) CALB (1mg, 2% w/w) was added. The reaction
mixture was stirred for 1 day. After filtration, the crude was
extracted with EtOAc (3 × 10mL). The organic layers were
washed brine (2× 10mL) and dried over anhydrousMgSO4. The
solvents were removed under vacuum. The crude of the reaction
was purified under silica gel chromatography (75/25 to 25/75:
CH2Cl2/EtOAc) to give 42.4mg of 16-B1-PhytoP2 (88% yield).
Rf = 0.05 (50/50: CH2Cl2/EtOAc);
1H NMR (500MHz, CDCl3):
δ = 6.79 (d, J = 15.8Hz, 1H), 6.25 (dd, J = 5.9, 15.8Hz, 1H),
4.28 (q, J = 6.1Hz, 1H), 2.65–2.63 (m, 2H), 2.43–2.41 (m, 2H),
2.32 (t, J = 7.3Hz, 2H), 2.25 (t, J = 7.5Hz, 2H), 1.65 (quint, J =
7.3Hz, 2H), 1.61–1.58 (m, 2H), 1.36–1.33 (m, 2H), 1.33–1.24 (m,
6H), 0.97 (t, J = 7.4Hz, 3H); 13C NMR (125MHz, CDCl3): δ =
211.4, 180.2, 165.0, 142.7, 141.3, 125.4, 75.0, 35.3, 35.2, 31.4, 30.4,
30.0 (2C), 29.9, 27.0, 25.9, 24.2, 11.0; HRMS (ESI+) calculated for
C18H29O4 [M+H]
+ 309.2066, found 309.2064; [α]20D = + 22.6
(c 10, CHCl3).
Ent-16-B1-PhytoP (ent-2)
Similar to the above, from (R)-15 the reaction gave ent-16-
B1-PhytoP (ent-2) (36.8mg, 77% yield). Rf = 0.05 (50/50:
CH2Cl2/EtOAc);
1H NMR (500 MHz, CDCl3): δ = 6.80 (d, J =
15.7Hz, 1H), 6.25 (dd, J = 5.9, 15.7Hz, 1H), 4.29 (q, J = 5.9Hz,
1H), 2.67–2.63 (m, 2H), 2.43–2.41 (m, 2H), 2.32 (t, J = 6.9Hz,
2H), 2.26 (t, J = 6.8Hz, 2H), 1.68–1.56 (m, 4H), 1.41–1.24 (m,
8H), 0.98 (t, J = 7.2Hz, 3H); 13C NMR (125 MHz, CDCl3): δ =
211.4, 180.1, 164.9, 142.7, 141.2, 125.4, 75.0, 35.3, 35.2, 31.4, 30.4,
30.03, 30.02, 29.9, 27.0, 25.9, 24.2, 11.0; HRMS (ESI+) calculated
for C18H29O4 [M+H]
+ 309.2066, found 309.2081; [α]20D = −
22.1 (c 10, CHCl3).
Result and Discussion
Our initial target was 9-L1-PhytoP, and while the ethyl
group at the 2-position of 1,3-cyclopentanedione could be
introduced using the Ramachary protocol (Ramachary and
Kishor, 2008), we started with commercial and affordable 2-
ethyl-1,3-cyclopentanedione (Scheme 2). Protection of one of
the ketone groups was done by O-alkylation with commercial
TMSCHN2 in a MeOH/Et2O solution to give the corresponding
enol ether 3. The latter is then treated with a solution of vinyl
magnesium bromide in THF to provide the desired conjugated
dienenone system 4 in 61% yield over 2 steps (Fisher et al., 1988).
Having in hand 4, the synthesis of racemic coupling partner
5 is easily achieved by allylic oxidation of commercial methyl
10-undecenoate with SeO2and tBuOOH in refluxing CH2Cl2
overnight in 61% yield (Scheme 3). The corresponding enone
compound 6 was obtained by Swern oxidation sequence in 79%
yield.
Enzymatic resolution of 5 was carried out using Candida
antartica lipase B (CALB) with vinyl acetate in hexane on
gram scale. After overnight conversion, non-reactive alcohol and
acetate compounds are separated by silica gel to afford (S)-5 in
99% ee and 45% yield and (R)-5-Ac in 46% yield and 93% ee.
(R)-5-Ac can be submitted to a second enzymatic resolution, after
methanolysis, CALB conversion and methanolysis to afford (R)-
5 in an improved 99% ee in 76% overall yield from (R)-5-Ac.
Absolute configurations are determined using the corresponding
mandelic ester derivatives (Chataigner et al., 1998).
Cross-metathesis (CM) between diene (or electron deficient
diene) and alkene (or electron deficient alkene) are nowadays
quite widespread in the literature (Grubbs, 2004), however CM
between conjugated dienone and allylic alcohol, or even more
complex electron deficient enone substrate have never been
attempted to the best of our knowledge (Wojtkielewicz, 2013).
CM was initially investigated between allylic alcohol (S)-5
and 2-ethyl-3-vinyl-cyclopentenone 4 (Scheme 4). Two second
SCHEME 2 | Access to 2-ethyl-3-vinyl-cyclopentenone 4.
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SCHEME 3 | Synthesis of alkene precursors.
SCHEME 4 | Synthesis of 9-L1-PhytoP, its enantiomer and 9-oxo-L1-PhytoP.
SCHEME 5 | Synthesis of cyclopentenone 13.
generation N-heterocyclic carbene ruthenium (II) complexes
i.e., Grubbs 2nd generation (G-II) and Hoveyda-Grubbs 2nd
generation (HG-II) were screened, and the best conditions were
2.5 mol% of catalyst in CH2Cl2 at room temperature for 2 days
followed by another batch for 3 days. Later six other catalysts
from Omega Cat System (M831-SIPr, M832-SIPr, M843-SIPr,
M73-SIPr, M71-SIPr, and M71-SIMes) were tested, but HG-II
proved to be the best giving 40% of our desired compound (S)-7.
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G-II gave lower yield (33%) and the 6 others from Omega Cat
System even lower (0–17%). Heating the reaction or microwave
condition resulted in poor recovering yield. Homodimerized
cyclopentenone of 4 were observed to a minor extent (10%).
Similarly, CM of enantiomer (R)-5 gave compound (R)-7 in
42% yield. The final step in this short synthesis of 9-L1-PhytoP
consisted of the enzymatic saponification of the carboxylic ester
group of (S)-7 using CALB (2% w/w) in MeCN/Phosphate buffer
(pH = 7) (82% yield). Ent-9-L1-PhytoP was also recovered in
85% yield. Both syntheses permitted in a matter of 6–7 steps the
recovery of more than 60mg of those natural products.
To access 9-oxo-9-L1-PhytoP, which we believe is a potential
metabolite of 1, we decided to perform a CM between
cyclopentenone 4 and enone 6. Reaction conditions proved
to be smoother than before as only one batch of 2.5 mol%
of HG-II catalyst in refluxing CH2Cl2 for 5 h afforded the
corresponding coupling product with complete consumption of
starting materials. Purification was only performed to remove
catalyst because substrate 8 slowly decomposed over silica
gel. We also noted that dimers of 4 and 6 were formed in
greater amount than from the previous CM with allylic alcohol
5, even if we did not intend to recover them for further
SCHEME 6 | LiTMP dimerization of 1,2-epoxybutane.
characterization. Saponification of 9-oxo-9-L1-PhytoP methyl
ester 8 inMeCN/Phosphate buffer (pH= 7) with CALB provided
after column chromatography 9-oxo-9-L1-PhytoP 9 (58% yield, 2
steps) contaminated with 5% of Z isomer.
To access our second target, 16-B1-PhytoP, the synthesis of
methyl 8-oxooctanoate 10was necessary to perform the reductive
alkylation procedure to introduce the 2-alkyl-substituent of
1,3-cyclopentanedione (Scheme 5). Therefore, ozonolysis of
cyclooctene followed by in situ transformation of the methoxy-
hydroperoxide intermediate gave the desired aldehyde 10 in 68%
yield on gram scale (Claus and Scheiber, 1986). The reductive
alkylation of 1,3-cyclopentanedione with methyl 8-oxooctanoate
10 and Hantzsch ester under L-proline-catalysis (5mol%)
following Ramachary procedure (Ramachary and Kishor, 2008),
provided 2-alkylated cyclopentane-1,3-dione at rt in CH2Cl2 for
4 h. Further reaction with TMSCHN2 in Et2O/MeOH furnished
O-methylated compound 11 in 91% over 2 steps. In order to
introduce the vinyl moiety, enzymatic saponification with CALB
lipase was sought, leading to the carboxylic acid compound 12,
followed by vinyl magnesium bromide addition in THF. Late
stage esterification with TMSCHN2 provided dienone compound
13 in 50% yield over 3 steps.
What remained to be accomplished was the metathesis
CM between 13 and enantiomerically enriched penten-3-ol
or corresponding penten-3-one. Resolution of penten-3-ol was
already described in the literature by Sharpless asymmetric
epoxidation (Moslin and Jamison, 2006), however we could not
achieve the level of enantiopurity reported (66% vs. >90% ee).
While no report for lipase enzymatic resolution of penten-3-
ol was reported, we screened a panel of commercially available
lipases but did not reach a significant level of enantiopurity
either, which could certainly be explained due to the relatively
small difference between the vinyl and the ethyl groups.
However, it is well known that CM can also be performed
starting with the homodimer of the olefin partner (Finnegan
et al., 2006). Fortunately, a very simple procedure to access
SCHEME 7 | Synthesis of 16-B1-PhytoP, its enantiomer and 16-oxo-B1-PhytoP.
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enantiomerically pure 2-ene-1,4-diols of such, from simple
dimerization of terminal epoxides was reported by Hodgson’s
research group.(Hodgson et al., 2005) Therefore commercially
available (S)-1,2-epoxybutane was added to LiTMP in tBuOMe at
−5◦C to give after purification homodimer (+)-14 in 36% yield
(Scheme 6). Similarly, (R)-1,2-epoxybutane yielded homodimer
(-)-14 in 38% yield. CM study started with cyclopentenone 13
(1 eq) and (−)-14 (0.7 eq) in CH2Cl2 at rt for 4 days as previously
described above, but with 2.5 mol% HG-II added every day
(Scheme 7). These conditions afforded 16-B1-PhytoP methyl
ester (S)-15 in 49% yield. The last step consisted of enzymatic
saponification with CALB yielding 16-B1-PhytoP 2 in 88% yield.
The synthesis of ent-16-B1-PhytoP ent-2 was achieved in similar
conditions and yields from precursor (+)-14.
The last target, 16-oxo-16-B1-PhytoP 17 was obtained
from commercially available pent-1-en-3-one (2 eq) and
cyclopentenone 13 (1 eq) in refluxing CH2Cl2 for 4 h and
only 2.5 mol% of HG-II to furnish 16-oxo-16-B1-PhytoP
methyl ester 16. CALB enzymatic saponification resulted in
16-oxo-16-B1-PhytoP 17 in 47% yield over 2 steps.
Conclusion
In this paper, we have developed a rapid and flexible
synthetic strategy for 2,3-substituted cyclopentenone
phytoprostanes which can permit development of synthetic
analogs from commercially available materials within a
few steps. This strategy can compete with the Boland’s
one in terms of the number of steps and flexibility with a
limitation in terms of yield in the CM compare to the Heck
reaction (higher yield of coupling and scale), however no
protecting group of the side chains was required in our
strategy.
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